Argus Upgrades UnitedHealth Group (UNH) to Buy

Go back to Argus Upgrades UnitedHealth Group (UNH) to Buy

UnitedHealth Group (UNH) PT Raised to $161 at Oppenheimer

July 20, 2016 9:54 AM EDT

Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating and bumped his price target on UnitedHealth Group (NYSE: UNH) to $161.00 (from $145.00) following solid Q2 results despite ACA challenges.

Wiederhorn commented, "UNH reported 2Q16 adjusted EPS of $1.96 (GAAP: $1.81, includes $0.15 amortization), vs. OPCO/Street of $1.91/$1.89.... More

UnitedHealth Group (UNH) PT Raised to $155 at Credit Suisse Post Q2

July 20, 2016 8:56 AM EDT

Credit Suisse analyst S. Fidel reiterated an Outperform rating and lifted his price target on UnitedHealth Group (NYSE: UNH) to $155.00 (from $148.00) following Q2 results.

Fidel commented, "UNH's growth thesis continues to separate from the rest of the pack: While UNH's challenges in the public exchanges once again put a damper on an otherwise strong 2Q report, the company appears to be setting up increasingly well for 15%+ EPS growth in 2017. First, the planned exits... More

Leerink Partners Reiterates Outperform on UnitedHealth Group (UNH) Following 2Q Beat and Raise

July 20, 2016 7:18 AM EDT

Leerink Partners reiterated an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $165.00 (from $155.00), following the company's 2Q earnings report. UNH reported a 7c EPS beat and $1.5B revenue beat with a conservative EPS guidance raise of 2.5c.

Analyst Ana Gupte commented, "Importantly, the Consolidated MLR miss of 40 bps was underpinned by a meaningfully conservative incremental estimated loss in the ObamaCare... More